Redcliffe Labs
Guest
Jul 14, 2025
5:18 AM
|
The Double Marker Test by Redcliffe Labs is a crucial first-trimester prenatal screening designed to evaluate the risk of chromosomal abnormalities in the fetus, such as Down syndrome (Trisomy 21) and Trisomy 18. Conducted between the 9th and 13th week of pregnancy, this blood test measures two key biochemical markers: Free Beta hCG and PAPP-A (Pregnancy-Associated Plasma Protein A). When combined with an NT (Nuchal Translucency) scan, the Double Marker Test provides a more accurate risk assessment to guide further diagnostic decisions if necessary. It is a non-invasive test that helps expecting parents make informed choices early in the pregnancy. With advanced testing accuracy, timely reporting, and compassionate care, Redcliffe Labs ensures a safe and reassuring screening experience for every mother-to-be.
|
